Japanese CML treatment patterns revealed in large database study

This study looked at how 754 people with chronic myeloid leukemia (CML) in Japan were treated with drugs called tyrosine kinase inhibitors (TKIs) between 2011 and 2019. Researchers used a hospital database to track which TKIs patients received, how often they switched or stopped treatment, and the costs involved. The goal was to describe real-world treatment patterns, not to test a new therapy.